Eclipse Bio is proud to recognize breast cancer awareness month and is committed to developing cutting-edge RNA technologies that will revolutionize the world of RNA medicine and human health.

Dysregulation of m6A states has been implicated in breast and other varieties of cancer. Our m6A-eCLIP technology enables high resolution maps of the epitranscriptome with single nucleotide resolution transcriptome-wide.